Axa lifted its holdings in Aetna Inc (NYSE:AET) by 16.6% in the third quarter, according to its most recent disclosure with the SEC. The institutional investor owned 274,863 shares of the company’s stock after purchasing an additional 39,125 shares during the period. Axa owned approximately 0.08% of Aetna worth $43,706,000 at the end of the most recent reporting period.
Several other hedge funds have also made changes to their positions in AET. FMR LLC lifted its stake in Aetna by 73.8% in the second quarter. FMR LLC now owns 13,736,800 shares of the company’s stock worth $2,085,659,000 after acquiring an additional 5,833,567 shares during the last quarter. Janus Henderson Group PLC lifted its stake in Aetna by 9,446.2% in the second quarter. Janus Henderson Group PLC now owns 4,328,900 shares of the company’s stock worth $657,255,000 after acquiring an additional 4,283,553 shares during the last quarter. Capital World Investors lifted its stake in Aetna by 8.9% in the second quarter. Capital World Investors now owns 20,769,004 shares of the company’s stock worth $3,153,358,000 after acquiring an additional 1,688,767 shares during the last quarter. Orbimed Advisors LLC lifted its stake in Aetna by 57.3% in the third quarter. Orbimed Advisors LLC now owns 1,396,500 shares of the company’s stock worth $222,057,000 after acquiring an additional 508,600 shares during the last quarter. Finally, Samlyn Capital LLC purchased a new position in Aetna in the second quarter worth approximately $77,170,000. Hedge funds and other institutional investors own 88.01% of the company’s stock.
Aetna Inc (AET) opened at $179.70 on Friday. The company has a market cap of $58,235.26, a price-to-earnings ratio of 17.49, a PEG ratio of 1.63 and a beta of 0.61. Aetna Inc has a 1-year low of $116.04 and a 1-year high of $192.37. The company has a debt-to-equity ratio of 0.52, a current ratio of 0.53 and a quick ratio of 0.53.
Aetna (NYSE:AET) last announced its earnings results on Tuesday, October 31st. The company reported $2.45 EPS for the quarter, beating analysts’ consensus estimates of $2.06 by $0.39. The business had revenue of $14.99 billion for the quarter, compared to analysts’ expectations of $15.12 billion. Aetna had a net margin of 2.93% and a return on equity of 21.84%. The company’s quarterly revenue was down 5.0% on a year-over-year basis. During the same period in the previous year, the company posted $2.07 EPS. analysts predict that Aetna Inc will post 9.78 earnings per share for the current fiscal year.
The firm also recently announced a quarterly dividend, which will be paid on Friday, January 26th. Stockholders of record on Thursday, January 11th will be issued a $0.50 dividend. The ex-dividend date of this dividend is Wednesday, January 10th. This represents a $2.00 dividend on an annualized basis and a dividend yield of 1.11%. Aetna’s payout ratio is 37.04%.
AET has been the subject of a number of recent research reports. Citigroup lifted their price target on shares of Aetna from $183.00 to $197.00 and gave the stock a “buy” rating in a research note on Thursday, November 2nd. Argus reiterated a “buy” rating and issued a $185.00 price target (up previously from $165.00) on shares of Aetna in a research note on Tuesday, September 12th. Zacks Investment Research upgraded shares of Aetna from a “hold” rating to a “buy” rating and set a $174.00 price target for the company in a research note on Thursday, October 12th. Jefferies Group lifted their price target on shares of Aetna from $163.00 to $165.00 and gave the stock a “hold” rating in a research note on Friday, October 13th. Finally, Piper Jaffray Companies reiterated a “hold” rating and issued a $187.00 price target on shares of Aetna in a research note on Friday, November 3rd. Twelve equities research analysts have rated the stock with a hold rating and fourteen have issued a buy rating to the company. Aetna has a consensus rating of “Buy” and a consensus price target of $175.19.
In other Aetna news, President Karen S. Lynch sold 15,271 shares of the business’s stock in a transaction on Monday, September 18th. The shares were sold at an average price of $161.91, for a total value of $2,472,527.61. Following the transaction, the president now directly owns 64,261 shares of the company’s stock, valued at approximately $10,404,498.51. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Insiders own 0.90% of the company’s stock.
ILLEGAL ACTIVITY WARNING: This story was posted by The Lincolnian Online and is the sole property of of The Lincolnian Online. If you are accessing this story on another publication, it was illegally stolen and reposted in violation of US and international trademark and copyright law. The legal version of this story can be read at https://www.thelincolnianonline.com/2017/12/16/axa-increases-position-in-aetna-inc-aet.html.
Aetna Inc is a diversified healthcare benefits company. The Company operates through three segments: Health Care, Group Insurance and Large Case Pensions. It offers a range of traditional, voluntary and consumer-directed health insurance products and related services, including medical, pharmacy, dental, behavioral health, group life and disability plans, medical management capabilities, Medicaid healthcare management services, Medicare Advantage and Medicare Supplement plans, workers’ compensation administrative services and health information technology (HIT) products and services.
Receive News & Ratings for Aetna Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aetna and related companies with MarketBeat.com's FREE daily email newsletter.